Mural Oncology (MURA) Institutional Ownership $2.75 -0.01 (-0.36%) Closing price 04:00 PM EasternExtended Trading$2.76 +0.00 (+0.18%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Mural Oncology (NASDAQ:MURA)CurrentInstitutional OwnershipPercentage80.21%Number ofInstitutional Buyers(last 12 months)26TotalInstitutional Inflows(last 12 months)$14.82MNumber ofInstitutional Sellers(last 12 months)16TotalInstitutional Outflows(last 12 months)$3.15M Get MURA Insider Trade Alerts Want to know when executives and insiders are buying or selling Mural Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MURA Institutional Buying and Selling by Quarter Mural Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025 Acorn Capital Advisors LLC1,269,715$1.60M1.0%-1.3%7.353% 5/16/2025 Goldman Sachs Group Inc.109,922$139K0.0%-5.1%0.637% 5/15/2025 Armistice Capital LLC1,722,000$2.17M0.0%+1.3%9.972% 5/15/2025 Solas Capital Management LLC887,995$1.12M0.6%-30.0%5.142% 4/29/2025 Concurrent Investment Advisors LLC22,500$28K0.0%N/A0.131% 2/18/2025 Alpine Global Management LLC80,964$261K0.1%-61.6%0.476% 2/17/2025 Squarepoint Ops LLC175,502$565K0.0%+1.4%1.031% 2/17/2025 Two Sigma Advisers LP26,000$84K0.0%N/A0.153% 2/17/2025 Two Sigma Investments LP65,150$210K0.0%+12.0%0.383% 2/17/2025 Prosight Management LP466,822$1.50M0.4%-18.2%2.743% Get the Latest News and Ratings for MURA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mural Oncology and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Millennium Management LLC168,255$542K0.0%-11.1%0.989% 2/17/2025 Bridgeway Capital Management LLC29,300$94K0.0%N/A0.172% 2/17/2025 Acorn Capital Advisors LLC1,286,079$4.14M2.3%N/A7.556% 2/14/2025 Jane Street Group LLC21,117$68K0.0%N/A0.124% 2/14/2025 Northern Trust Corp39,966$129K0.0%+22.0%0.235% 2/14/2025 RBF Capital LLC338,669$1.09M0.1%-5.9%1.990% 2/14/2025 Price T Rowe Associates Inc. MD26,905$87K0.0%-28.6%0.158% 2/14/2025 Alpine Global Management LLC80,964$261K0.1%-61.6%0.476% 2/13/2025 Raymond James Financial Inc.56,176$181K0.0%N/A0.330% 2/13/2025 Renaissance Technologies LLC238,465$768K0.0%+17.4%1.401% 2/12/2025 Geode Capital Management LLC181,029$583K0.0%-4.7%1.064% 2/12/2025 Nicollet Investment Management Inc.94,737$305K0.1%-4.3%0.557% 2/11/2025 Virtu Financial LLC40,025$129K0.0%N/A0.235% 2/6/2025 Raymond James Financial Inc.56,176$181K0.0%N/A0.330% 1/13/2025 FNY Investment Advisers LLC15,000$48K0.0%-25.0%0.088% 11/16/2024 Geode Capital Management LLC190,056$595K0.0%+2.6%1.115% 11/15/2024 RBF Capital LLC359,900$1.13M0.1%-7.3%2.112% 11/15/2024 Point72 Asset Management L.P.108,715$340K0.0%N/A0.638% 11/15/2024 Centiva Capital LP203,706$638K0.0%-9.3%1.195% 11/15/2024 Point72 Asia Singapore Pte. Ltd.12,574$39K0.0%-52.8%0.074% 11/14/2024 Verition Fund Management LLC340,000$1.06M0.0%-33.4%1.996% 11/13/2024 BNP Paribas Financial Markets28,048$88K0.0%-71.0%0.165% 11/13/2024 FMR LLC20,580$64K0.0%+124.7%0.121% 11/9/2024 Primecap Management Co. CA140,045$438K0.0%-40.5%0.822% 11/8/2024 Commerce Bank12,423$39K0.0%N/A0.073% 9/16/2024 Cubist Systematic Strategies LLC31,243$98K0.0%N/A0.185% 9/16/2024 Point72 Asia Singapore Pte. Ltd.26,642$84K0.0%N/A0.157% 8/15/2024 Armistice Capital LLC1,688,000$5.30M0.1%N/A9.974% 8/15/2024 Point72 Asia Singapore Pte. Ltd.26,642$84K0.0%N/A0.157% 8/14/2024 Squarepoint Ops LLC167,644$526K0.0%N/A0.991% Now I look stupid. Real stupid... (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.8/14/2024 Cubist Systematic Strategies LLC31,243$98K0.0%N/A0.185% 8/13/2024 Canada Pension Plan Investment Board22,360$70K0.0%N/A0.132% 8/9/2024 Primecap Management Co. CA235,551$740K0.0%N/A1.392% 8/9/2024 Renaissance Technologies LLC232,100$729K0.0%N/A1.371% 8/9/2024 Dimensional Fund Advisors LP22,563$71K0.0%N/A0.133% 8/8/2024 Nicollet Investment Management Inc.98,016$308K0.1%N/A0.579% 8/6/2024 Acadian Asset Management LLC318,536$998K0.0%N/A1.882% 8/5/2024 BBR Partners LLC10,000$31K0.0%N/A0.059% 8/1/2024 Rhumbline Advisers10,786$34K0.0%N/A0.064% 7/9/2024 Harbor Capital Advisors Inc.36,769$115K0.0%N/A0.217% (Data available from 1/1/2016 forward) MURA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MURA shares? During the previous two years, 37 institutional investors and hedge funds held shares of Mural Oncology. The most heavily invested institutionals were Armistice Capital LLC ($2.17M), Acorn Capital Advisors LLC ($1.60M), Prosight Management LP ($1.50M), Solas Capital Management LLC ($1.12M), RBF Capital LLC ($1.09M), Verition Fund Management LLC ($1.06M), and Acadian Asset Management LLC ($998K).Learn more on MURA's institutional investors. What percentage of Mural Oncology stock is owned by institutional investors? 80.21% of Mural Oncology stock is owned by institutional investors. Learn more on MURA's institutional investor holdings. Which institutional investors have been buying Mural Oncology stock? Of the 26 institutional investors that purchased Mural Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($1.71M), Acorn Capital Advisors LLC ($1.29M), Acadian Asset Management LLC ($318.54K), Renaissance Technologies LLC ($267.50K), Primecap Management Co. CA ($235.55K), Squarepoint Ops LLC ($170.11K), and Raymond James Financial Inc. ($112.35K). How much institutional buying is happening at Mural Oncology? Institutional investors have bought a total of 4,706,823 shares in the last 24 months. This purchase volume represents approximately $14.82M in transactions. Which Mural Oncology major shareholders have been selling company stock? Of the 16 institutional investors that sold Mural Oncology stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Solas Capital Management LLC ($381.01K), Alpine Global Management LLC ($259.25K), Verition Fund Management LLC ($170.85K), Prosight Management LP ($103.80K), Primecap Management Co. CA ($95.51K), BNP Paribas Financial Markets ($68.69K), and RBF Capital LLC ($49.47K). How much institutional selling is happening at Mural Oncology? Institutional investors have sold a total of 1,235,713 shares in the last 24 months. This volume of shares sold represents approximately $3.15M in transactions. Related Companies Prime Medicine Institutional Ownership INmune Bio Institutional Ownership Voyager Therapeutics Institutional Ownership Molecular Partners Institutional Ownership Eledon Pharmaceuticals Institutional Ownership Organigram Institutional Ownership Inhibrx Institutional Ownership ProQR Therapeutics Institutional Ownership TuHURA Biosciences Institutional Ownership DiaMedica Therapeutics Institutional Ownership This page (NASDAQ:MURA) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mural Oncology plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Mural Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
